Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain

Experimental Neurology

Volumn 149, Issue 2, 1998, Pages 341-348

  Hendriks, Lydia ^a   De Jonghe, Chris ^a   Lübke, Ursula ^a   Woodrow, Sarah ^a   Vanderhoeven, Inge ^a   Boons, Jef ^a   Cras, Patrick ^a   Martin, Jean Jacques ^a   Van Broeckhoven, Christine ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Alzheimer's disease; Immunohistochemistry; Polyclonal antibody; Presenilin 1; Tau

Indexed keywords

POLYCLONAL ANTIBODY;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELLULAR DISTRIBUTION; CHROMOSOME 14; FAMILIAL DISEASE; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0032005524     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6739     Document Type: Article

References (34)

1. Borchelt D. R., Thinakaran G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky T., Prada C.-M., Kim G., Seekins S., Yager D., Slunt H. H., Wang R., Seeger M., Levey A. I., Gandy S. E., Copeland N. G., Jenkins N. A., Price D. L., Younkin S. G., Sisodia S. S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratioin vitroin vivo. Neuron. 17:1996;1005-1013.
2. Busciglio J., Hartmann H., Lorenzo A., Wong C., Baumann K., Sommer B., Staufenbiel M., Yankner B. A. Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J. Neurosci. 17:1997;5101-5107.
3. Citron M., Westaway D., Xia W. M., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St. George Hyslop P. S., Selkoe D. J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3:1997;67-72.
4. Cribbs D. H., Chen L., Bende S. M., LaFerla F. M. Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain. Am. J. Pathol. 148:1996;1797-1806.
5. Cruts M., Backhovens H., Wang S.-Y., Van Gassen G., Theuns J., De Jonghe C., Wehnert A., De Voecht J., De Winter G., Cras P., Bruyland M., Datson N., Weissenbach J., den Dunnen J. T., Martin J.-J., Hendriks L., Van Broeckhoven C. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum. Molec. Genet. 4:1995;2363-2372.
6. Cruts M., Hendriks L., Van Broeckhoven C. The presenilin genes: A new gene family involved in Alzheimer disease pathology. Hum. Mol. Genet. 5:1996;1449-1455.
7. Cruts, M. C. Van Broeckhoven, Presenilin mutations in Alzheimer's disease, Hum. Mut.
8. Doan A., Thinakaran G., Borchelt D. R., Slunt H. H., Ratovitsky T., Podlisny M., Selkoe D. J., Seeger M., Gandy S. E., Price D. L., Sisodia S. S. Protein topology of presenilin-1. Neuron. 17:1996;1023-1030.
9. Duff K., Eckman C., Zehr C., Yu X., Prada C.-M., Perez-Tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M. N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
10. Elder G. A., Tezapsidis N., Carter J., Shioi J., Bouras C., Li H.-C., Johnston J. M., Efthimiopoulos S., Friedrich V. L. Jr., Robakis N. K. Identification and neuron specific expression of the S182/presenilin 1 protein in human and rodent brain. J. Neurosci. Res. 45:1996;308-320.
11. Hendriks L., Thinakaran G., Harris C. L., De Jonghe C., Martin J.-J., Sisodia S. S., Van Broeckhoven C. Processing of presenilin 1 in brains of Alzheimer's disease patients and controls. NeuroReport. 8:1997;1717-1721.
12. Huynh D. P., Ho V. V., Pulst S.-M. Characterization and expression of presenilin 1 in mouse brain. NeuroReport. 7:1996;2423-2428.
13. Lah J. J., Heilman C. J., Nash N. R., Rees H. D., Yi H., Counts S. E., Levey A. I. Brain J. Neurosci. 17:1997;1971-1980.
14. Lee M. K., Slunt H. H., Martin L. J., Thinakaran G., Kim G., Gandy S. E., Seeger M., Koo E., Price D. L., Sisodia S. S. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissue. J. Neurosci. 16:1996;7513-7525.
15. Lemere C. A., Lopera F., Kosik K. S., Lendon C. L., Ossa J., Saido T. C., Yamaguchi H., Ruiz A., Martinez A., Madrigal L., Hincapie L., Arango J. C., Anthony D. C., Koo E. H., Goate A. M., Selkoe D. J., Arango V. J. C. The E280A presenilin-1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med. 2:1996;1146-1150.
16. Li X., Greenwald I. Membrane topology of theC. elegans. Neuron. 17:1996;1015-1021.
17. Kovacs D. M., Fausett H. J., Page K. J., Kim T.-W., Moir R. D., Merriam D. E., Hollister R. D., Hallmark O. G., Mancini R., Felsenstein K. M., Hyman B. T., Tanzi R. E., Wasco W. Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med. 2:1996;224-229.
18. Mann M. A., Iwatsubo T., Cairns N. J., Lantos P. L., Nochlin D., Sumi S. M., Bird T. D., Poorkaj P., Hardy J., Hutton M., Prihar G., Crook R., Rossor M. N., Haltia M. Amyloid β protein (Aβ) deposition in chromosome 14-linked Alzheimer's disease: Predominance of Aβ42(43). Ann. Neurol. 40:1996;149-156.
19. Martin J.-J., Gheuens J., Bruyland M., Cras P., Vandenberghe A., Beyreuther K., Masters C., Dom R., Ceuterick C., Lübke U., Van Heuverswijn H., De Winter G., Van Broeckhoven C. Early-onset Alzheimer's disease in 2 large Belgian families. Neurology. 41:1991;62-68.
20. Mercken M., Vandermeeren M., Lübke U., Six J., Boons J., Van de Voorde A., Martin J.-J., Gheuens J. Monoclonal antibody with selective specificity for Alzheimer's disease tau are directed against phosphatase-sensitive epitopes. Acta. Neuropathol. (Berlin). 84:1992;265-272.
21. Mercken M., Takahashi H., Honda T., Sato K., Murayama M., Nakazato Y., Noguchi K., Imahori K., Takashima A. Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett. 389:1996;297-303.
22. Moussaoui S., Czech C., Pradier L., Blanchard V., Bonici B., Gohin M., Imperato A., Revah F. Immunohistochemical analysis of presenilin-1 expression in the mouse brain. FEBS Lett. 383:1996;219-222.
23. Murphy G. M. Jr, Forno L. S., Ellis W. G., Nochlin D., Levy-Lahad E., Poorkaj P., Bird T. D., Jiang Z., Cordell B. Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease. Am. J. Pathol. 149:1996;1839-1846.
24. Page K., Hollister R., Tanzi R. E., Hyman B. T. In situ hybridisation analysis of presenilin 1 mRNA in Alzheimer disease and in lesioned rat brain. Proc. Natl. Acad. Sci. USA. 93:1996;14020-14024.
25. Podlisny M. B., Citron M., Amarante P., Sherringhton R., Xia W., Zhang J., Diehl T., Levesque G., Fraser P., Haass C., Koo E. H. ME. H., Seubert P., St. George-Hyslop P., Teplow D. B., Selkoe D. J. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol. Dis. 3:1997;325-337.
26. Quarteronet D., Pradier L., Czech C., Delalonde L., Burgevin M. C., Doble A., Petitet F. Localization of presenilin-1 mRNA in rat brain. NeuroReport. 7:1996;2587-2591.
27. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β -protein similar to that in the senile plaques of Alzheimer's disease is increasedin vivo. Nature Med. 2:1996;864-870.
28. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J. F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sansosu P., Polinsky R. J., Wasco W., Da Silva H. A. RH. A., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., St. George-Hyslop P. Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
29. Suzuki T., Nishiyama K., Murayama S., Yamamoto A., Sato S., Kanazawa I., Sakaki Y. Regional and cellular presenilin-1 gene expression in human and rat tissues. Biochem. Biophys. Res. Commun. 219:1996;708-713.
30. Thinakaran G., Borchelt D., Lee M. K., Slunt H. H., Spitzer L., Kim G., Ratovitsky R., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A. I., Gandy S. E., Jenkins N. A., Copeland N. G., Price D. L., Sisodia S. S. Endoproteolysis of presenilin 1 and accumulation of processed derivativesin vivo. Neuron. 17:1996;181-190.
31. Uchihara T., el Hachimi H. K., Duyckaerts C., Foncin J. F., Fraser P. E., Levesque L., St George-Hyslop P. H., Hauw J. J. Widespread immunoreactivity of presenilin in neurons of normal and Alzheimer's disease brains: Double-labeling immunohistochemical study. Acta Neuropathol. (Berlin). 92:1996;325-330.
32. Walter J., Capell A., Grünberg J., Pesold B., Schindzielorz A., Prior R., Podlisny M. B., Fraser P., St George-Hyslop P., Selkoe D. J., Haass C. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2:1996;673-691.
33. Weber L. L., Leissring M. A., Yang A. J., Glabe C. G., Cribbs D. H., LaFerla F. M. Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques. Exp. Neurol. 143:1997;37-44.
34. Wisniewski T., Palha J. A., Ghiso J., Frangione B. S182 protein in Alzheimer's disease neuritic plaques. Lancet. 346:1995;1366.